Spanish regions look set to overspend health budgets
This article was originally published in Clinica
Spain's eight autonomous regions have spent 75% of their annual health budgets in the first eight months of the year, reveals Insalud's subdirectorate general of economic expenditure. This compares unfavourably with the national health agency itself, which has slightly underspent for the period. Those regions which have taken control of their own budgets have already spent Pta 1,505,182 million ($11,852 million) of their annual budget of Pta 1,994,363 million, while Insalud-controlled health expenditure was 60% of its annual budget of Pta 1,295,208 million. In the present situation, there is no mechanism to increase budgets during the year.
You may also be interested in...
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
Vildagliptin formulation prices fall by over 70% following the expiry of a patent held by Novartis in India. The innovator, meanwhile, is cashing in on co-marketing agreements with Indian partners like USV and Cipla
For providers and medtech manufacturers alike, the decade ahead will be a time of coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market entry criterion, but companies will have to adapt to evolving health care delivery models. The stakes are implausibly high. Will they be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?